The Patent Finder

Promis Neurosciences Inc.

Also on record
Records under this name other than the patents Promis Neurosciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Promis Neurosciences Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,779,629Compositions Comprising Cyclic Peptides Derived from an Abeta Peptide
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,286,469Humanized Antibodies Binding to Amyloid-Beta (A-BETA)
Held by another company
In force
 · High confidence
In forceHigh confidence
US 12,071,472Methods of Reducing Amyloid Beta (A-BETA) Propagation and Toxicity Induced by A-Beta Oligomers Using Antibodies Specific to A-Beta Oligomers
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,404,321Conformation-Specific Epitopes in Alpha-Synuclein, Antibodies Thereto and Methods Related Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,053,510FasR ANTIBODIES AND METHODS OF USE
Lapsed on the fee record
Ended Aug 21, 2026 · High confidence
Lapsed on the fee recordEnded Aug 21, 2026High confidence
US 8,709,422Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
Lapsed on the fee record
Ended Apr 29, 2026 · Low confidence
Lapsed on the fee recordEnded Apr 29, 2026Low confidence
US 7,887,803Methods and compositions to treat misfolded-SOD1 mediated diseases
Term ended
Term ended Aug 12, 2025 · USPTO record
Term endedTerm ended Aug 12, 2025USPTO record
US 9,637,552Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated DIseases
Lapsed on the fee record
Ended May 2, 2025 · Low confidence
Lapsed on the fee recordEnded May 2, 2025Low confidence
US 9,523,697Detection of pathogenic abeta using an epitope protection assay
Lapsed on the fee record
Ended Dec 20, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 20, 2024USPTO record
US 7,439,324ALS-specific peptide composition
Term ended
Term ended Dec 11, 2024 · USPTO record
Term endedTerm ended Dec 11, 2024USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited